EurekaMag.com logo
+ Translate

The use of clofazimine as treatment for Mycobacterium fortuitum in a cat


, : The use of clofazimine as treatment for Mycobacterium fortuitum in a cat. Feline Practice 22(3): 7-9

In a mature male cat with a history of chronic non-healing ventral abdominal wall abscess, an atypical mycobacterial granuloma caused by M. fortuitum was diagnosed by histopathology and culture. The organism was sensitive to a recently described anti-leprosy drug, clofazimine (Lamprene).

(PDF 0-2 workdays service)

Accession: 002530227

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Weiszfeiler J.; Jokay I.; Karczag E.; Almassy K.; Somos P., 1968: Taxonomic studies on mycobacteria on the basis of their antigenic structure mycobacterium bovis mycobacterium kansasii mycobacterium avium mycobacterium balnei mycobacterium simiae new species mycobacterium phlei mycobacterium smegnatis mycobacterium fortuitum. Acta Microbiologica Academiae Scientiarum Hungaricae 15(1): 69-76

Wallace, R.J.; Brown, B.A.; Onyi, G.O., 1991: Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. MICs of imipenem, cefoxitin, cefmetazole, and amoxicillin-clavulanic acid were determined against 100 strains of Mycobacterium fortuitum and 200 strains of Mycobacterium chelonae. Imipenem and cefmetazole were more active against M. fortuitum than...

Casal, M.J.; Rodriguez, F.C.; Luna, M.D.; Benavente, M.C., 1987: In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. The in vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae (M. chelonei) to ticarcillin in combination with calvulanic acid (CA)...

Schinsky, M.F.; Morey, R.E.; Steigerwalt, A.G.; Douglas, M.P.; Wilson, R.W.; Floyd, M.M.; Butler, W.Ray.; Daneshvar, M.I.; Brown-Elliott, B.A.; Wallace, R.J.; McNeil, M.M.; Brenner, D.J.; Brown, J.M., 2004: Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. The Mycobacterium fortuitum third biovariant complex (sorbitol-negative and sorbitol-positive) contains unnamed taxa first characterized in 1991. These organisms can cause respiratory infections, a spectrum of soft tissue and skeletal infections,...

Lescenko, P.; Matlova, L.; Navratil, S.; Vavra, O.; Pavlik, I., 2001: Occurrence of mycobacteria in aquarium fish and isolation of Mycobacterium fortuitum from environmental samples from aquarium Vyskyt mykobakterii u akvarijnich ryb a izolace Mycobacterium fortuitum z vodniho prostredi akvaria. Unknown

Gay J.D.; Deyoung D.R.; Roberts G.D., 1984: In vitro activities of norfloxacin and ciprofloxacin against mycobacterium tuberculosis mycobacterium avium complex mycobacterium chelonei mycobacterium fortuitum and mycobacterium kansasii. Antimicrobial Agents & Chemotherapy 26(1): 94-96

Yew, W.W.; Lau, K.S.; Tse, W.K.; Wong, C.F., 1992: Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience. Clinical Infectious Diseases 15(6): 1046-1047

Yew, W.W.; Kwan, S.Y.; Wong, P.C.; Lee, J., 1990: Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections. Two patients with Mycobacterium fortuitum and one patient with Mycobacterium chelonae lung infections were treated with ofloxacin and imipenem respectively. Of the former two, one had underlying inactive pulmonary tuberculosis and bronchiectasis a...

Dalovisio, J.R.; Pankey, G.A.; Wallace, R.J.; Jones, D.B., 1981: Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. The antimicrobial agents amikacin and doxycycline, which are not conventionally considered for use in treatment of mycobacterial infections, inhibit growth of Mycobacterium fortuitum and Mycobacterium chelonei in vitro. Ten patients were treated w...

Wallace, R.J.; Swenson, J.M.; Silcox, V.A.; Bullen, M.G., 1985: Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. One hundred twenty-three patients with nonpulmonary infections due to Mycobacterium fortuitum or Mycobacterium chelonei were treated by wound debridement and with chemotherapy on the basis of in vitro susceptibilities of the organism. Of 76 patien...